Medford, MA, United States of America

Ben McNally

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ben McNally: Innovator in DNA Sequencing Technologies

Introduction

Ben McNally, a notable inventor based in Medford, Massachusetts, has made significant contributions to the field of DNA sequencing. With a portfolio of three patents, McNally's work demonstrates his commitment to advancing technology in genetic sequencing, paving the way for enhanced methodologies and applications.

Latest Patents

McNally's recent patents underscore his innovative approach to DNA sequencing. One of his key inventions is a DNA sequencing reaction additive, which introduces methods and compositions utilizing 5-Chloro-2-methyl-4-isothiazolin-3-one in sequencing reactions. This invention particularly focuses on deoxynucleoside triphosphates that incorporate a 3'-O position capped by a disulfide-based 3′-terminator group. The inventive methods include the incorporation of thiol-containing compounds and scavengers, promising advancements in sequencing technologies such as Sequencing by Synthesis.

Another significant patent revolves around thiol-containing cleave reagents and oxidative washes, presenting similar core concepts. McNally's inventions facilitate the use of deoxynucleoside triphosphates with a cleavable protecting group and a detectable label, again enhancing the capabilities of future sequencing technologies.

Career Highlights

Throughout his career, McNally has garnered experience working with reputable companies in the biotechnology sector. Notably, he has been associated with Isoplexis Corporation and Qiagen Sciences, LLC. His extensive work in these organizations has contributed to his development of innovative sequencing technologies.

Collaborations

In his professional journey, Ben McNally has collaborated with esteemed colleagues, including Luisa Andruzzi and Angela DeLucia. These collaborations have likely fostered a rich exchange of ideas and advancements in their collective areas of expertise, further enhancing the impact of McNally's inventions.

Conclusion

Ben McNally's contributions to DNA sequencing technology reflect significant strides in the field of genetics. Through his patents and collaborations, he continues to shape the future of sequencing methodologies, demonstrating the vital role of innovation in scientific advancement. His work not only elevates the capabilities of genetic research but also holds promising implications for future applications in various biological sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…